Recent Posts
Connect with:
Wednesday / August 17.
HomeminewsAward-winning Long-COVID Study

Award-winning Long-COVID Study

Dr Bettina Hohberger, from the Eye Clinic at the Friedrich Alexander University in Erlangen, Germany, has received the Heidelberg Engineering Xtreme Research Award 2022 for her diagnostic insights into long COVID.

Dr Hohberger used optical coherence tomography angiography (OCTA) on the Spectralis platform in an experimental setting to assess therapeutic responses of patients impaired by chronic fatigue syndrome (CFS). In a recent publication,1 she described her findings of CFS in relation to a preceding COVID-19 infection (known as ‘long-COVID syndrome).

Dr Hohberger’s research is making substantial contributions to medical insights into long COVID and may help refine treatment options

The research demonstrates the importance of high-resolution OCTA and the potential of OCT imaging beyond ophthalmic pathologies, and furthers understanding of this technology and its clinical capabilities.

“Scientific research relies on high-resolution images and precise measurements, and we are fortunate to have OCTA devices with a high resolution to help us detect and image physiological changes, discern patterns, and formulate potential treatment options,” said Dr Hohberger.

“It is an honour for me to accept this award from Heidelberg Engineering. With this technology, we were able to gain novel insights into the field of long COVID.”

The Xtreme Research Award recognises talented researchers for their outstanding projects that provide tangible benefits to ophthalmic science, eye care, and improved patient care. Krysten Williams, Head of Global Marketing and Education at Heidelberg Engineering, said the collaboration with international scientists, clinicians, and industry, is what allows Heidelberg Engineering to develop innovative solutions in ophthalmology and beyond.

“Dr Hohberger’s research is making substantial contributions to medical insights into long COVID and may help refine treatment options,” said Ms Williams.

Heidelberg Engineering celebrated Dr Hohberger’s achievement at the formal Xtreme Research Award ceremony at the 2022 annual ARVO meeting in Denver, Colorado.


  1. Hohberger, Bettina et al. (2021). Case Report: Neutralization of Autoantibodies Targeting G-Protein-Coupled Receptors Improves Capillary Impairment and Fatigue Symptoms After COVID-19 Infection. Frontiers in Medicine. https://doi.org/10.3389/fmed.2021.754667


By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.